Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » By Affiliations
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top 20 Journal Cited
 » Top 20 Cited
 » Top 20 Author Cited
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Screening for 3435C>T and 2677G>T/A Polymorphisms of Multi-Drug Resistance (MDR1) Gene in Malay Patients with Leukemia

Badrul Hisham Y., and Rosline H,, and Mohd Ros S., and Norsa’adah B., and Abdul Aziz B., and Narazah M.Y., (2006) Screening for 3435C>T and 2677G>T/A Polymorphisms of Multi-Drug Resistance (MDR1) Gene in Malay Patients with Leukemia. Malaysian Journal of Biochemistry and Molecular Biology, 14 (1). pp. 18-24. ISSN ISSN 1511-2616

Full text not available from this repository.

Official URL: http://ejum.fsktm.um.edu.my/ArticleInformation.aspx?ArticleID=583

Affiliations

Universiti Sains Malaysia. School of Medical Sciences. Human Genome Centre
Universiti Sains Malaysia. School of Medical Sciences. Dept. of Haematology
Universiti Sains Malaysia. School of Medical Sciences. Human Genome Centre
Universiti Sains Malaysia. School of Medical Sciences. Unit of Biostatistics & Research Methodology
Universiti Sains Malaysia. School of Medical Sciences. Dept. of Medicine
Universiti Sains Malaysia. Advance Medical and Dental Institute

Abstract

The prevalence of 2677G>T and 3435C>T polymorphisms of the multi-drug resistance (MDR1) gene was found to be different in many populations and it was significantly influenced by ethnicities. The mechanism on how these two single nucleotide polymorphisms (SNPs) play a role in regulating the MDR1 expression especially in leukemia patients is still unclear and controversial. The objective of this study was to evaluate the distribution of 3435C>T and 2677G>T/A polymorphisms among Malay patients diagnosed to have leukemia (n=101) by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) based assays. The genotype frequencies for homozygous genotype GG, heterozygous genotype GT and genotype GA and homozygous mutation genotype TT or AA in exon 21 were reported as 36.9%, 48.5%, 5.8% and 8.7%, respectively. In exon 26, the frequencies were 34.0%, 50.5% and 15.5% for the homozygous wild type CC, heterozygous mutation CT and homozygous mutation TT, respectively. There were no association found between the distribution of SNPs in both exons with the types of leukemia and sex of patients. Therefore, further clinical studies in a larger sample size should be carried out in order to find the association between sex and types of leukemia in distribution of common SNPs in Malay patients with leukemia. The significant implication of these common SNPs to the level of P-gp expression in Malay patients with leukemia that might contribute to the chemotherapy resistance should be carried out as a future study.

Item Type:Journal
Keywords:P-glycoprotein, Multi-drug resistance, SNPs, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Malays
Subjects:Q Science, Computer Science
R Medicine, Dentistry, Pharmacy, Nursing
ID Code:2191

1. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S. et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001;297: 1137-43.

2. Juliano, R.L. and Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.

3. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. and Pastan, I. Expression of a multidrugresistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987; 84: 265-9.

4. Sato, H., Gottesman, M.M., Goldstein, L.J., Pastan, I., Block, A.M., Sandberg, A.A. and Preisler, H.D. Expression of the multidrug resistance gene in myeloid leukemias. Leuk Res 1990; 14: 11-21.

5. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., lovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R. et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukaemia: a Southwest Oncology Group Study. Blood 1999; 94: 1086-99.

6. Goasguen, J.E., Dossot, J.M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P.Y., Chaperon, J. and Fauchet, R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukaemia: prognostic implications. Blood 1993; 81: 2394-8.

7. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473-8.

8. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U. and Roots, I. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001; 69: 169-74.

9. Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Taylor, A., Xie, H.G., McKinsey, J., Zhou, S. et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70: 189-99.

10. Illmer, T., Schuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gotthard, S., Freund, D., Schakel, U., Ehninger, G. and Schaich, M. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukaemia patients. Cancer Res 2002; 62: 4955-62.

11. Chakravarti, A. To a future of genetic medicine. Nature 2001; 409: 822-3.

12. Ameyaw, M.M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, G.O., Githang’a, J., Indalo, A. et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001; 11: 217-21.

13. Tang, K., Wong, L.P., Lee, E.J., Chong, S.S. and Lee, C.G. Genomic evidence for recent positive selection at the human MDR1 gene locus. Hum Mol Genet 2004;, 13: 783-97.

14. Tang, K., Ngoi, S.M., Gwee, P.C., Chua, J.M., Lee, E.J., Chong, S.S. and Lee, C.G. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002; 12: 437-50.

15. Jamroziak, K., Balcerczak, E., Mlynarski, W., Mirowski, M. and Robak, T. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol J Pharmacol 2002; 54: 495-500.

16. Lotsch, J., Skarke, C. and Geisslinger, G. Simultaneous screening for three mutations in the ABCB1 gene. Genomics 2003; 82: 503-10.

17. Efferth, T., Sauerbrey, A., Steinbach, D., Gebhart, E., Drexler, H.G., Miyachi, H., Chitambar, C.R., Becker, C.M., Zintl, F. and Humeny, A. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukaemia. Int J Oncol 2003;23: 509-17.

18. Linder, M.W., Prough, R.A. and Valdes, R., Jr. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency. Clin Chem 1997; 43: 254-66.

19. Calado, R.T., Falcao, R.P., Garcia, A.B., Gabellini, S.M., Zago, M.A. and Franco, R.F. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells. Haematologica 2002;87: 564-8.

20. Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I. and Gottesman, M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361-98.

21. Jamroziak, K., Mlynarski, W., Balcerczak, E., Mistygacz, M., Trelinska, J., Mirowski, M., Bodalski, J. and Robak, T. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukaemia. Eur J Haematol 2004; 72: 314

Repository Staff Only: item control page